Bryce Point Capital, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Bryce Point Capital, LLC
- $345 Billion
- Q4 2024
A detailed history of Bryce Point Capital, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 19,607 shares of RYTM stock, worth $1.13 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
19,607Holding current value
$1.13 Million% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
200Shares Held
64.5MCall Options Held
834KPut Options Held
78.6K-
Black Rock Inc. New York, NY6.74MShares$388 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$378 Million0.29% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$368 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$350 Million4.44% of portfolio
-
Perceptive Advisors LLC New York, NY3.56MShares$205 Million4.87% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.21B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...